Reproductive Medicine Associates of New York Delivers Breakthrough Research at 73rd ASRM Annual Meeting

NEW YORK, Nov. 2, 2017 /PRNewswire/ -- Members of the Manhattan-based fertility center, Reproductive Medicine Associates of New York (RMA of NY, www.rmany.com) present 33 scientific abstracts at the 73nd annual meeting of the American Society of Reproductive Medicine (ASRM, asrm.com) in San Antonio, Texas. Study topics range from access to quality care, genomic and personalized medicine, and embryology laboratory precision.

"The team at RMA of NY is honored to be recognized by ASRM for our scientific and clinical contributions.  We are committed to sharing our research findings and collaborating with our peers to improve clinical decision-making and to enhance patient outcomes," stated Dr. Alan B. Copperman, Co-Director of RMA of NY and Vice Chairman of Obstetrics and Gynecology and Director of the Division of Reproductive Endocrinology and Infertility at the Icahn School of Medicine at Mount Sinai Hospital in New York.

In one study, researchers used natural language processing to identify 207 patients being treated for depression with selective serotonin reuptake inhibitors (SSRIs), during their IVF cycle. The goal was to understand if maternal SSRI exposure prior to IVF affects the rate of embryo development.  In an oral presentation, Dr. Carlos Hernandez of RMA of NY used data to inform clinicians regarding the care of their patients undergoing treatment for depression, and reassured them that taking necessary medication would not be harmful.

Another RMA of NY study evaluated the role of oocyte aging on each of the chromosomes. A total of 6,751 embryos from 1,244 patients were analyzed using next generation sequencing (NGS) to detect chromosomal aneuploidy. Women under the age of 35 showed more errors in the larger chromosomes compared to older women. In addition, younger women had fewer errors in their smaller chromosomes.  Dr. Christine Briton-Jones, Director of Laboratories at RMA of NY, concluded that possible telomeric exchanges resulting in aneuploidy are more common in younger women, while pericentromeric exchanges are more common in older women.

A third study demonstrated that the length of time a chromosomally normal embryo was in storage did not correlate with the embryo's reproductive potential or perinatal outcome. Over 2,300 vitrified euploid blastocysts were cryopreserved from four months to nearly five years prior to being thawed and transferred. The team of investigators found the information reassuring for patients undergoing embryo banking or storing supernumery embryos for future family building.

Copperman added, "The reproductive journey is different now than it was 20 years ago, 10 years ago, and will be months from now. By analyzing big data, accessing machine learning algorithms and artificial intelligence, focusing on genomic and personalized medicine, and ultimately relying on compassionate and consistent clinical care, physicians can improve reproductive outcomes for their patients. We are proud to contribute to science, and look forward to participating in the advancement of the field of reproductive medicine for years to come."

About Reproductive Medicine Associates of New York, LLP
Reproductive Medicine Associates of New York (RMA of NY) is a global leader in delivering personalized, precise, and compassionate reproductive care. The integrated team of physicians and scientists at RMA of NY has extensive experience and training in reproductive endocrinology, fertility, and urology, and consistently reports high success rates to the Society for Assisted Reproductive Technology (SART) and the Centers for Disease Control and Prevention (CDC). As part of the Icahn School of Medicine at Mount Sinai, RMA of NY performs scientific, educational, and clinical functions. RMA of NY has been recognized as a leader in LGBTQ reproductive care, for women choosing single or same-sex motherhood, and for women and men pursuing fertility preservation for elective and medical indications.

Headquartered in Midtown Manhattan, RMA of NY has three patient care facilities in Manhattan, as well as offices in Brooklyn, Garden City, and White Plains, NY. Additionally, RMA of NY has patient care facilities in Mexico City, Mexico. For more information, visit www.rmany.com.

Media Contact: Allysa Mizerek, Reproductive Medicine Associates of New York, 212-756-5777, [email protected]

SOURCE Reproductive Medicine Associates of New York

Related Links

http://www.rmany.com